The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review
Brandon M. Meyers, Jennifer J. Knox, David Liu, Deanna McLeod, Ravi Ramjeesingh, Vincent C. Tam, Howard J. Lim
Topics & Concepts
SorafenibMedicineBevacizumabOncologyDurvalumabAtezolizumabInternal medicineHepatocellular carcinomaClinical trialRegimenImmunotherapyCancerNivolumabChemotherapyHepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersCholangiocarcinoma and Gallbladder Cancer Studies